FDA Approves First Blood Test for Alzheimer’s, Marking a Historic Shift in Early Detection

EU Commission Approves Perioperative Opdivo Regimen for High-Risk Resectable NSCLC

ONCOLife Warmly Welcomes Dr İlkiz Er Dağ as ONCOLife Project Director

FDA Approves Emrelis as the First Targeted ADC for High c-Met Expressing Lung Cancer

START Doses First Patient in Trial of mRNA-4106, a Pan-Tumor Therapy for Solid Tumors

10-Year Results Confirm Pertuzumab Combo Extends Survival in HER2+ Breast Cancer

V Foundation and Cancer Vaccine Coalition Partner to Accelerate Breast Cancer Vaccine

EpCAM-Targeting ADC CX-2051 Shows Promising Efficacy in Advanced Colorectal Cancer

Leucid Bio Doses First Patient in Trial of LEU011, a CAR-T Therapy for Solid Tumors

Oncologists Struggle with Innovation Overload: 'The Growing Chasm in Cancer Care'

A Turning Point: Avutometinib + Defactinib Earn Accelerated FDA Approval for Ovarian Cancer

POTOMAC Trial: Durvalumab Plus BCG Boosts Outcomes in Early-Stage Bladder Cancer

FDA Announces AI Strategy with First AI-Assisted Scientific Pilot to Accelerate Drug Review

Enhertu Plus THP Outperforms Standard Chemotherapy in Early-Stage HER2+ Breast Cancer

Elraglusib Shows Survival Benefit in First-Line Metastatic Pancreatic Cancer Trial

Adcentrx’s Nectin-4 ADC, ADRX-0706, Earns FDA Fast Track for Advanced Cervical Cancer

New AI-Powered Urine Test Detects Prostate Cancer with Higher Precision than PSA

Zongertinib Demonstrates 71% Response Rate in HER2-Mutant Lung Cancer Treatment

Bria-IMT’s Early Promise: Biomarkers Signal Path to Personalized Therapy in Breast Cancer

Combined Tissue and Liquid Biopsies Improve Survival in Advanced Solid Tumors

Bayer Launches First-in-Human Trial of Targeted Alpha Therapy for Advanced Liver Cancer

First AI-Driven Diagnostic Tool Wins FDA Breakthrough Designation for Lung Cancer

First-Ever KRAS G12D Inhibitor Zoldonrasib Shows 61% Response Rate in Lung Cancer

Gut Bacteria as Co-Therapy: MB097’s Role in Overcoming Resistance in Melanoma

Merck Expands US Bio Manufacturing with $1B Wilmington Facility for KEYTRUDA

New Hope for SPG47: BlackfinBio’s BFB-101 Gene Therapy Advances with FDA Approval

Pembrolizumab Improves Event-Free Survival in Resectable Head and Neck Cancer

Sasanlimab Plus BCG Shows Significant Survival Benefit for NMI Bladder Cancer

Nimbus Launches First Human Trial of Promising WRN Inhibitor for MSI-H Cancers

Boehringer and Tessellate Partner to Develop Treatments for Hard-to-Treat Cancers